Novo Nordisk A/S B SHRS AdrhNVOHETF
13F holders, Q3 2025 (September 30)2holders +1
1new positions
0sold out
$30.09avg. 13F price*
At the end of Q3 2025, 2 institutions reported holding Novo Nordisk A/S B SHRS Adrh (NVOH) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were UBS Group AG ($2K) and Bfsg, LLC ($602).
- Company
- Novo Nordisk A/S B SHRS Adrh
- Filed as
- PRECIDIAN ETFS TR (Q3 2025)
- CUSIP
- 74016W841
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $602 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 20 shares bought and 254 shares sold, net −234 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| UBS Group AG | 0.00% | Reduce -75.8% | 81 | $2K |
| Bfsg, LLC | 0.00% | New | 20 | $602 |
"% of holder's portfolio" is NVOH's weight in each manager's 13F, not the share of Novo Nordisk A/S B SHRS Adrh the manager owns.